Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
NCT00373178Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone, metformin in type 2 diabetes mellitus (T2DM), sponsored by Aristotle University of Thessaloniki. Started Jan 2005; status: completed.
02
Drugs
rosiglitazonemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00373178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373178.